ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $53,488,471 | 22.38% |
MPM BioImpact LLC | 1,745,943 | $34,098,267 | 8.85% |
Saturn V Capital Management LP | 342,071 | $7,027,867 | 5.83% |
Boxer Capital, LLC | 2,154,058 | $42,068,752 | 2.22% |
RA Capital Management | 4,417,259 | $86,269,068 | 1.75% |
BVF INC/IL | 1,810,835 | $35,365,608 | 1.49% |
Octagon Capital Advisors LP | 445,000 | $8,690,850 | 1.35% |
Integral Health Asset Management, LLC | 270,000 | $5,273,100 | 1.11% |
Zebra Capital Management LLC | 13,946 | $272 | 0.95% |
Advisors Preferred, LLC | 90,973 | $1,686,639 | 0.72% |
TANG CAPITAL MANAGEMENT LLC | 216,700 | $4,232,151 | 0.62% |
DAFNA Capital Management LLC | 98,560 | $1,924,877 | 0.54% |
Prairiewood Capital, LLC | 32,269 | $630,214 | 0.46% |
Artal Group S.A. | 400,000 | $7,812 | 0.44% |
683 Capital Management, LLC | 150,000 | $2,929,500 | 0.25% |
SECTORAL ASSET MANAGEMENT INC | 57,762 | $1,128,092 | 0.22% |
Endurant Capital Management LP | 21,041 | $410,931 | 0.17% |
Worth Venture Partners, LLC | 12,766 | $268,469 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 243,500 | $4,755,555 | 0.12% |
Candriam S.C.A. | 739,517 | $14,442,090 | 0.10% |
External links
This page lists ITEOS THERAPEUTICS INC's shareholders in Q4 2022. To view ITEOS THERAPEUTICS INC's shareholder history, click here.